This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of parotid gland
C3_PAROTIDGLAND
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
341 |
4. Check minimum number of eventsNone |
341 |
5. Include endpointsNone |
341 |
6. Filter based on genotype QC (FinnGen only) |
311 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of parotid gland
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of parotid gland, including Hilmo
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck, including Hilmo
- Solid cancers
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 311 | 150 | 161 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 64.47 | 61.24 | 67.49 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 321
- Matched controls
- 3210
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
226.0
307.7
192
21
ELB40
NOMESCO Finland
Partial parotidectomy
179.1
261.4
129
12
C07.70
ICD-10 Finland
Malignant tumor of the superficial part of the parotid gland
+∞
224.1
188
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
28.3
147.3
110
58
ELB50
NOMESCO Finland
Total parotidectomy
994.7
136.3
124
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
99.2
90
*
H02AB02
ATC
dexamethasone; systemic
46.0
94.4
57
15
XX3DW
NOMESCO Finland
Time consuming IT work
16.6
88.0
82
65
130
Kela drug reimbursment
Malignant tumour
+∞
79.6
73
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
17.9
73.7
64
44
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
68.2
63
*
A03FA01
ATC
metoclopramide; systemic, rectal
7.9
67.4
123
235
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
15.8
64.9
60
46
C07.71
ICD-10 Finland
Malignant tumor in the deep part of the parotid gland
+∞
60.3
56
*
8550/3-C07.9
ICD-O-3
Acinar cell carcinoma of parotid gland
+∞
60.3
56
*
A04AA01
ATC
ondansetron; systemic, rectal
19.5
57.7
47
28
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
18.6
57.6
48
30
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
143.9
57.0
59
5
WZC00
NOMESCO Finland
Treatment plan or consultation
5.7
53.8
174
553
WF002
NOMESCO Finland
Radical radiotherapy
210.7
52.7
53
*
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
210.7
52.7
53
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
191.9
48.3
49
*
G51.0
ICD-10 Finland
Bell palsy
14.1
43.5
42
34
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
42.7
40
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
12.9
39.5
40
35
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
39.4
37
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.5
37.1
135
448
R4190
NOMESCO Finland
Nutritional therapy
13.5
34.7
34
28
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
195.7
34.5
35
*
8430/3-C07.9
ICD-O-3
Mucoepidermoid carcinoma of parotid gland
+∞
34.0
32
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
34.0
32
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
130.5
33.4
35
*
C07
ICD-10 Finland
Malignant neoplasm of parotid gland
+∞
32.9
31
*
8070/3-C07.9
ICD-O-3
Squamous cell carcinoma, NOS, of parotid gland
+∞
31.8
30
*
WX402
NOMESCO Finland
General anaesthesia
4.3
31.5
108
337
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
122.2
31.3
33
*
C08.89
ICD-10 Finland
Malignant overall tumor the large salivary glands anna or unspecified histology
+∞
29.6
28
*
8500/3-C07.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of parotid gland
+∞
29.6
28
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
319.4
29.3
29
*
Z51.5
ICD-10 Finland
Palliative care
7.9
28.7
42
60
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
27.5
26
*
JN4BD
NOMESCO Finland
Extensive body CT
7.3
27.2
43
67
A04AA02
ATC
granisetron; systemic, transdermal
294.4
27.2
27
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
26.4
25
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
102.0
26.1
28
*
XW000
NOMESCO Finland
Bone marrow biopsy
10.9
26.0
29
29
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
41.1
24.4
30
8
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
+∞
23.2
22
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
90.2
23.0
25
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
+∞
22.1
21
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
22.1
21
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
22.1
21
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
21.1
20
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
21.1
20
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
51.6
20.5
24
5
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
20.0
19
*
8200/3-C07.9
ICD-O-3
Adenoid cystic carcinoma of parotid gland
+∞
20.0
19
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
8.2
19.0
26
34
L03AA02
ATC
filgrastim; parenteral
+∞
18.9
18
*
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
6.5
18.1
31
52
L03AA13
ATC
pegfilgrastim; parenteral
100.7
17.8
19
*
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
100.7
17.8
19
*
N02AA05
ATC
oxycodone; systemic
3.3
17.6
80
291
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.7
17.5
162
870
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
5.6
16.9
34
67
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
16.8
16
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
16.8
16
*
C08.99
ICD-10 Finland
Malignant tumor of unspecified large salivary gland, other or unspecified histology
+∞
16.8
16
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
16.8
16
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
16.8
16
*
EBA15
NOMESCO Finland
Extraction of multiple teeth
6.0
16.3
30
54
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
35.4
15.9
20
6
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
15.8
15
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
15.8
15
*
8562/3-C07.9
ICD-O-3
Epithelial-myoepithelial carcinoma of parotid gland
+∞
15.8
15
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
15.8
15
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
89.6
15.7
17
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
167.8
15.6
16
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
167.8
15.6
16
*
SAA03
NOMESCO Finland
Extended examination of mouth
2.6
15.3
144
768
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
15.1
137
717
ZXE20
NOMESCO Finland
More than three and less than five hours
3.5
15.0
60
200
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.3
15.0
26
44
L02BB03
ATC
bicalutamide; oral
+∞
14.7
14
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
14.7
14
*
115
Kela drug reimbursment
Breast cancer
+∞
14.7
14
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
13.6
13
*
8140/3-C07.9
ICD-O-3
Adenocarcinoma, NOS, of parotid gland
+∞
13.6
13
*
ELB60
NOMESCO Finland
Radical parotidectomy sacrificing the facial nerve
+∞
13.6
13
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
13.6
13
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
145.9
13.6
14
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
145.9
13.6
14
*
S04
ICPC
Lump/swelling localized
3.3
13.5
57
196
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.8
13.3
43
124
CBF10
NOMESCO Finland
Shortening of canthal ligaments and tarsal plate for ectropion
42.0
13.3
16
*
ZXA05
NOMESCO Finland
Left side
2.5
12.7
102
497
JN6AD
NOMESCO Finland
CT of torso and neck
25.5
12.6
17
7
116
Kela drug reimbursment
Prostate cancer
+∞
12.6
12
*
C08.94
ICD-10 Finland
Mucoepidermoid carcinoma of an unspecified large salivary gland
+∞
12.6
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.6
12
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
135.1
12.5
13
*
R4110
NOMESCO Finland
Physiotherapy
2.5
12.5
102
500
EBA10
NOMESCO Finland
Operative extraction of tooth
3.2
12.4
55
195
WZC30
NOMESCO Finland
Teaching
3.1
12.4
60
224
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
39.2
12.3
15
*
UDC00
NOMESCO Finland
Ear microscopy
3.6
12.2
44
137
WX110
NOMESCO Finland
Infiltration anesthesia
2.5
11.7
237
1707
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
67.5
11.7
13
*
AAH50
NOMESCO Finland
Cranial nerve anastomosis
+∞
11.5
11
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
11.5
11
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
11.5
11
*
ZZR00
NOMESCO Finland
Flap of skin
+∞
11.5
11
*
DEB00
NOMESCO Finland
Cortical mastoidectomy
+∞
11.5
11
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
124.3
11.5
12
*
SCA02
NOMESCO Finland
Preventive oral health care
3.5
11.1
41
129
ED1AA
NOMESCO Finland
Mandibular X-ray examination
45.0
11.0
13
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
45.0
11.0
13
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.8
10.8
61
247
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
62.1
10.7
12
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
113.6
10.5
11
*
8010/3-C07.9
ICD-O-3
Carcinoma, NOS, of parotid gland
+∞
10.5
10
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
10.5
10
*
4405
FHL
Partial removal of the parotid gland
+∞
10.5
10
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
10.5
10
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
10.5
10
*
9691/3-C07.9
ICD-O-3
Follicular lymphoma, grade 2 of parotid gland
+∞
10.5
10
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
10.4
132
772
H02.2
ICD-10 Finland
Lagophthalmos
19.6
10.4
15
8
A07AA02
ATC
nystatin; oral
3.8
10.1
32
91
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.2
9.9
20
23
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
18.2
9.5
14
8
L02AE02
ATC
leuprorelin; implant, parenteral
31.1
9.5
12
*
JN4AD
NOMESCO Finland
Body CT examination
3.6
9.5
33
100
CBJ50
NOMESCO Finland
Operation for ptosis of eyebrow
22.5
9.4
13
6
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
9.4
9
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
9.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
8502/3-C07.9
ICD-O-3
Secretory carcinoma of parotid gland
+∞
9.4
9
*
8941/3-C07.9
ICD-O-3
Carcinoma ex pleomorphic adenoma of parotid gland
+∞
9.4
9
*
ELB99
NOMESCO Finland
Other excision of salivary gland
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.4
9
*
EL3AT
NOMESCO Finland
Salivary gland biopsy with ultrasound guidance
+∞
9.4
9
*
9680/3-C07.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of parotid gland
+∞
9.4
9
*
8147/3-C07.9
ICD-O-3
Basal cell adenocarcinoma of parotid gland
+∞
9.4
9
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
9.4
9
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
11.1
9.4
17
16
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
37.8
9.1
11
*
QAJ10
NOMESCO Finland
Browlift
37.8
9.1
11
*
CBN30
NOMESCO Finland
Shortening of canthal ligament
37.8
9.1
11
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
8.7
156
1024
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
8.5
63
290
ZXA00
NOMESCO Finland
Right side
2.1
8.5
98
545
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
92.4
8.5
9
*
C08.90
ICD-10 Finland
Malignant tumor in unspecified large salivary gland without histology
+∞
8.4
8
*
9591/3-C07.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of parotid gland
+∞
8.4
8
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
8.4
8
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
8.4
8
*
A79
ICPC
Malignancy NOS
+∞
8.4
8
*
EMB10
NOMESCO Finland
Tonsillectomy
4.6
8.3
20
46
S18
ICPC
Laceration/cut
2.0
8.2
165
1120
K11.9
ICD-10 Finland
Disease of salivary gland, unspecified
22.7
8.1
11
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
8.0
166
1135
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
4.0
7.9
23
61
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
9.8
7.9
15
16
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
46.1
7.7
9
*
H02.1
ICD-10 Finland
Ectropion of eyelid
9.2
7.6
15
17
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
25.7
7.6
10
*
L57.0
ICD-10 Finland
Actinic keratosis
2.8
7.5
41
162
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
81.9
7.4
8
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.0
7.4
100
586
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
8982/3-C07.9
ICD-O-3
Myoepithelial carcinoma of parotid gland
+∞
7.3
7
*
QAB05
NOMESCO Finland
Revision of wound of skin of head or neck
+∞
7.3
7
*
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
+∞
7.3
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
7.3
7
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
7.3
7
*
4404
FHL
Complete removal of the parotid gland
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
7.3
7
*
DFF00
NOMESCO Finland
Pure tone audiometry
2.5
7.3
49
215
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
16.2
7.3
11
7
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
8.2
7.2
15
19
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.2
7.1
29
97
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
9.1
7.1
14
16
J01DB01
ATC
cefalexin; oral
2.2
7.0
262
2147
K11.2
ICD-10 Finland
Sialoadenitis
4.3
6.9
18
44
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
6.3
6.9
17
28
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.6
6.8
23
68
CBH25
NOMESCO Finland
Tarsorrhaphy
40.9
6.8
8
*
UJC01
NOMESCO Finland
Scopy of lower throat
12.6
6.6
11
9
ZZA00
NOMESCO Finland
Split skin graft
7.1
6.6
15
22
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.5
6.6
18
34
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.4
6.6
16
26
H61.2
ICD-10 Finland
Impacted cerumen
2.8
6.5
34
131
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
71.2
6.4
7
*
S77
ICPC
Malignant neoplasm of skin
71.2
6.4
7
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
18.5
6.3
9
5
ZXE00
NOMESCO Finland
One hour or less
1.9
6.3
118
766
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
6.3
6
*
2102A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Major salivary glands
+∞
6.3
6
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
WZC15, ,
NOMESCO Finland
+∞
6.3
6
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
QAJ30
NOMESCO Finland
Other facelift
27.3
6.3
8
*
EBB10
NOMESCO Finland
Insertion of dental implant
8.9
6.1
12
14
WX002
NOMESCO Finland
Sedation and analgesia
2.1
6.0
67
363
TQW40, ,
SPAT
2.5
6.0
39
168
B01AB04
ATC
dalteparin; parenteral
3.8
6.0
18
49
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
110
29
57.18
186.19
1.4
1.2
—
—
—
0
0
74
210
4.28
23.99
1.9
2.0
0.24
0.21
g/l
2.32
74
186
224
1387
3.04
18.86
13.0
5.9
3.86
4.33
e9/l
2.54
201
1184
73
256
3.40
17.01
6.5
2.3
226.25
230.79
u/l
0.20
73
242
123
602
2.69
15.62
3.1
2.0
—
—
—
0
0
183
1151
2.37
12.84
3.3
2.4
—
—
estimate
—
0
0
183
1166
2.32
12.26
6.3
3.6
35.92
35.70
g/l
0.21
170
1087
151
897
2.29
11.83
6.4
2.1
2.35
2.36
mmol/l
0.27
144
786
183
1191
2.25
11.33
7.3
5.6
1.20
1.21
mmol/l
0.52
172
1078
258
1979
2.55
10.32
11.1
5.6
84.30
76.48
u/l
1.13
244
1840
191
1331
2.07
9.15
8.5
6.1
1.21
1.21
mmol/l
0.04
161
1147
39
136
3.13
8.96
3.7
1.4
10.34
2.73
ug/l
0.66
34
99
92
557
1.91
6.04
4.9
2.1
2.45
2.44
mmol/l
0.09
86
490
107
692
1.82
5.67
2.9
2.5
329.45
357.60
umol/l
2.20
94
598
41
205
2.15
4.52
4.0
1.8
61.86
63.45
ml/min/173m2
0.12
22
80
199
1614
1.61
4.10
5.2
4.5
6.65
6.78
mmol/l
0.52
194
1524
19
74
2.67
3.62
1.9
1.3
3.15
1.39
ratio
—
10
46
7
9
7.92
3.57
1.0
1.1
—
—
—
0
0
45
254
1.90
3.57
3.7
3.2
—
—
—
0
0
285
2578
1.94
3.53
22.0
14.3
24.95
23.57
mg/l
0.33
248
2076
60
372
1.75
3.52
6.1
6.2
104.88
104.23
mmol/l
0.51
60
372
164
1311
1.51
3.32
14.3
15.5
1.26
1.31
inr
0.54
138
1093
47
278
1.81
3.22
2.6
1.9
12.28
5.71
umol/l
0.90
47
248
151
1198
1.49
3.10
2.7
2.5
83.46
77.56
nmol/l
1.47
133
1058
11
33
3.41
2.84
1.4
1.5
—
—
—
0
0
7
14
5.08
2.74
1.9
1.9
—
—
—
0
0
15
61
2.53
2.66
1.2
1.5
—
—
—
0
0
227
1996
1.47
2.51
5.0
4.5
13.80
12.14
mm/h
0.76
208
1846
123
973
1.43
2.42
2.7
3.2
1137.36
1438.53
ng/l
0.68
109
825
5
8
6.33
2.38
3.0
1.4
25.60
25.85
u/l
—
5
8
11
40
2.81
2.29
1.4
1.2
279.00
154.17
u/ml
—
5
18
60
420
1.53
2.17
2.9
2.3
2.19
2.25
g/l
0.37
51
387
271
2497
1.55
2.14
22.6
13.6
78.34
77.40
ml/min/173m2
0.36
256
2298
5
12
4.21
1.83
1.2
1.6
2.54
4.38
nmol/l
—
5
12
8
29
2.80
1.80
2.0
1.8
—
498.14
—
0
7
48
336
1.50
1.75
6.4
6.9
0.77
1.23
mmol/l
0.30
40
279
54
389
1.47
1.71
2.9
2.4
25.49
22.67
%
0.82
49
359
290
2744
1.59
1.67
15.3
10.2
25.28
25.87
u/l
0.19
279
2641
14
69
2.08
1.67
1.6
1.5
—
—
—
0
0
6
21
2.89
1.51
1.3
1.1
—
—
—
0
0
6
21
2.89
1.51
1.3
1.1
—
—
—
0
0
74
582
1.35
1.43
1.9
1.7
1.71
1.13
mg/l
0.49
58
455
56
421
1.40
1.42
3.2
2.8
2.48
2.70
e6/l
0.08
28
191
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
74
1.93
1.41
1.9
2.4
0.36
0.39
iu/ml
—
5
41
18
104
1.77
1.40
1.7
1.5
—
—
—
0
0
161
1422
1.27
1.29
2.4
2.8
—
—
—
0
0
294
2816
1.52
1.29
32.5
21.7
245.04
244.74
e9/l
0.03
284
2755
39
280
1.45
1.28
7.4
7.7
117.49
122.93
g/l
0.95
39
275
59
456
1.36
1.28
1.9
1.7
—
—
—
0
0
89
731
1.30
1.28
2.2
2.2
2.56
2.87
mg/l
0.74
67
623
294
2817
1.52
1.27
32.5
21.7
4.44
4.50
e12/l
1.53
283
2742
261
2456
1.34
1.22
6.1
5.3
2.03
1.94
mu/l
0.37
238
2243
14
79
1.81
1.19
1.5
1.7
—
—
—
0
0
0
34
0.00
1.16
0.0
1.2
—
7.79
—
0
25
13
73
1.81
1.12
1.6
1.2
—
—
—
0
0
9
46
1.98
1.04
5.3
3.1
7.56
11.15
pmol/l
—
9
46
53
663
0.76
1.04
4.2
4.0
1.02
1.02
kg/l
0.21
35
432
9
47
1.94
1.03
1.2
1.1
24.97
14.67
u/l
—
9
40
25
173
1.48
1.01
1.7
1.5
—
—
—
0
0
7
35
2.02
1.00
1.1
1.3
—
—
—
0
0
5
23
2.19
0.98
1.4
1.5
105.00
70.27
ng/l
—
5
23
57
459
1.29
0.95
3.0
2.6
0.92
1.40
e6/l
0.43
30
232
98
843
1.23
0.95
3.9
2.6
30.71
33.53
u/l
0.45
93
794
6
29
2.09
0.89
1.0
3.2
—
27.27
—
0
11
23
161
1.46
0.89
1.3
1.3
94.25
111.42
u/ml
—
8
69
21
145
1.48
0.87
6.6
8.9
15.76
15.94
%
0.07
21
140
41
516
0.76
0.85
1.3
1.3
12.47
38.48
iu/ml
4.19
12
160
85
729
1.23
0.84
3.6
2.8
0.36
0.39
e6/l
0.09
62
514
12
73
1.67
0.83
1.8
1.5
—
—
—
0
0
15
98
1.56
0.80
1.9
1.5
—
—
—
0
0
6
33
1.83
0.79
1.2
1.2
—
4.50
—
0
13
43
344
1.29
0.77
1.8
1.7
—
—
—
0
0
216
2031
1.19
0.76
5.1
4.2
14.82
14.92
pmol/l
0.23
199
1843
5
26
1.94
0.71
1.4
1.3
—
—
—
0
0
13
86
1.53
0.67
2.0
3.5
—
—
—
0
0
61
519
1.22
0.66
1.8
1.8
1123.87
1160.10
nmol/l
0.09
44
400
11
70
1.59
0.66
2.3
2.1
12.12
11.44
mg/l
0.14
11
65
29
225
1.32
0.66
1.5
1.4
—
—
—
0
0
10
62
1.63
0.66
1.3
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
5
90
0.55
0.56
2.0
1.9
43.60
41.08
nmol/l
—
5
83
98
1081
0.87
0.55
4.1
3.8
0.10
0.01
estimate
0.42
21
225
9
62
1.46
0.53
1.6
1.4
—
—
—
0
0
9
62
1.46
0.53
1.1
1.3
—
—
—
0
0
21
163
1.31
0.49
3.0
3.6
1.09
2.19
mmol/l
0.64
14
120
125
1157
1.13
0.48
1.8
1.9
1.21
1.32
mmol/l
0.81
98
969
54
616
0.85
0.47
1.7
1.9
431.18
11811448.70
pmol/l
0.50
38
508
8
58
1.39
0.42
1.0
1.1
1.48
1.50
g/l
—
8
58
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
8
59
1.36
0.41
1.4
1.8
235.00
294.34
mu/l
—
8
54
12
160
0.74
0.40
1.3
1.3
30.50
321.77
u/ml
2.01
12
149
181
1726
1.11
0.40
3.0
3.2
49.89
46.89
u/l
0.14
171
1620
151
1428
1.11
0.38
4.2
3.9
0.00
0.00
estimate
-0.00
29
283
42
478
0.86
0.37
1.2
1.3
9.08
12.35
u/ml
0.20
14
179
64
578
1.13
0.36
4.4
4.1
51.35
313.84
ng/l
2.51
55
465
68
747
0.89
0.36
4.0
3.4
0.00
0.00
estimate
-0.00
21
224
5
79
0.63
0.36
1.4
1.2
—
—
—
0
0
260
2538
1.13
0.34
6.3
7.1
38.65
39.92
mmol/mol
2.13
240
2369
37
324
1.16
0.32
1.8
1.8
—
—
—
0
0
131
1240
1.10
0.32
3.5
2.9
148.58
119.07
ug/l
0.52
110
1150
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
65
598
1.11
0.28
1.2
1.3
7.23
1.62
u/ml
0.66
14
149
8
63
1.28
0.28
1.3
1.2
—
—
—
0
0
147
1407
1.08
0.27
4.1
3.9
0.00
0.00
estimate
-0.00
27
281
8
66
1.22
0.27
1.1
1.2
—
23.21
—
0
8
5
74
0.67
0.26
1.0
1.3
—
—
—
0
0
6
84
0.71
0.24
1.7
1.6
—
—
—
0
0
19
222
0.85
0.24
1.8
2.0
3.04
3.35
ratio
0.65
14
183
122
1165
1.08
0.23
3.9
4.1
205.01
68.07
ng/l
0.36
89
871
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
5
39
1.29
0.23
1.0
1.3
—
—
—
0
0
129
1344
0.93
0.22
2.5
2.1
94.35
97.09
pmol/l
0.25
65
692
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
14.75
—
0
6
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
6.9
—
5.99
—
0
10
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
9.03
—
0
10
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
11.00
—
0
12
0
12
0.00
0.21
0.0
3.3
—
597.23
—
0
12
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
269
2650
1.09
0.20
5.7
6.3
2.57
2.63
mmol/l
0.46
240
2450
9
113
0.79
0.20
1.4
1.3
—
—
—
0
0
6
50
1.20
0.20
1.2
1.1
—
—
—
0
0
6
50
1.20
0.20
1.2
1.4
—
—
—
0
0
101
1057
0.94
0.20
3.6
3.4
7.30
7.56
mmol/l
0.24
75
891
21
184
1.15
0.19
1.9
1.5
—
—
—
0
0
149
1441
1.06
0.19
4.2
4.0
0.00
0.02
estimate
0.65
26
262
38
349
1.10
0.18
5.8
7.6
—
—
—
0
0
5
66
0.75
0.17
1.8
1.3
—
56.48
—
0
9
10
120
0.83
0.17
1.1
1.1
—
—
—
0
0
264
2605
1.08
0.16
5.1
5.4
4.51
4.53
mmol/l
0.09
241
2420
16
181
0.88
0.14
1.8
3.9
45.99
48.93
%
0.23
16
176
8
98
0.81
0.14
1.5
1.7
—
—
—
0
0
80
832
0.95
0.13
4.0
3.9
26.77
24.61
%
0.51
40
382
19
173
1.10
0.10
1.7
2.6
0.63
0.61
%
0.11
19
173
60
576
1.05
0.10
3.1
2.8
0.74
0.77
ug/l
0.10
40
368
19
174
1.10
0.09
1.4
1.9
—
—
—
0
0
102
1047
0.96
0.09
4.4
4.2
11.09
9.17
mg/mmol
0.13
62
655
250
2478
1.04
0.08
4.2
4.5
1.19
1.26
mmol/l
1.16
218
2263
90
877
1.04
0.08
4.0
2.2
62.74
60.86
u/l
0.06
82
813
19
176
1.08
0.07
1.7
2.6
1.23
1.20
%
0.05
19
176
261
2590
1.04
0.07
5.0
5.3
1.44
1.46
mmol/l
0.19
234
2388
8
74
1.08
0.07
1.4
1.1
—
—
—
0
0
260
2581
1.04
0.07
5.0
5.5
5.95
6.05
mmol/l
0.79
232
2343
106
1040
1.03
0.06
5.3
4.2
2.33
1.93
ug/l
0.58
92
922
38
365
1.05
0.06
1.4
1.5
—
—
—
0
0
91
893
1.03
0.05
1.8
1.7
19.09
20.04
nmol/l
0.22
74
753
15
140
1.07
0.04
1.5
1.5
—
—
—
0
0
20
190
1.06
0.04
1.6
2.1
—
—
—
0
0
28
270
1.04
0.03
1.8
2.8
4.46
4.49
kpa
0.03
28
259
37
362
1.02
0.01
4.7
5.3
35.17
32.54
%
0.71
24
230
15
156
0.96
0.00
1.4
3.0
25.61
25.07
mmol/l
0.30
15
150
32
314
1.02
0.00
2.8
3.1
5.85
5.75
kpa
0.27
32
305
21
211
0.99
0.00
1.6
3.0
126.29
129.21
g/l
0.23
21
204
20
203
0.98
0.00
4.7
6.3
24.61
24.60
mmol/l
0.00
20
196
32
325
0.98
0.00
1.6
1.4
—
—
—
0
0
80
795
1.01
0.00
3.9
3.9
0.00
0.00
estimate
-0.00
26
256
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
7.3
—
10.77
—
0
9
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.18
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
54
0.92
-0.00
1.2
1.8
—
—
—
0
0
8
82
0.97
-0.00
1.5
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
74
0.94
-0.00
1.4
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
102.40
—
0
5
8
81
0.99
-0.00
1.4
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
-0.00
1.0
1.4
—
—
—
0
0
5
49
1.02
-0.00
1.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
5.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.17
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PAROTIDGLAND – Malignant neoplasm of parotid gland
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).